Fundai

Rouz Darou Pharmaceutical Company (DARUZ) cash flow statement

Operating, investing and financing cash flows, and the closing balance

Ticker
DARUZ
Industry
Pharmaceuticals
Market
Tehran Stock Exchange

Latest periods

Latest 6-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/06/31To 1402/06/31To 1401/06/31To 1400/06/31
Cash generated from operations963,024614,0191,825,571-1,048,66283,680179,650
Cash payments for income tax-27,885-26,1220-8,630-9,1080
Net cash inflow (outflow) from operating activities935,139587,8971,825,571-1,057,29274,572179,650
Cash payments for purchase of property, plant and equipment-183,704-3,634-11,824-15,008-63,830-8,967
Cash receipts from dividends1,4244,603022518268
Cash receipts from interest on other investments62722646611,073286117
Net cash inflow (outflow) from investing activities-181,6531,195-11,358-503,913-63,026-13,537
Net cash inflow (outflow) before financing activities753,486589,0921,814,213-1,561,20511,546166,113
Cash receipts from facilities7,168,8443,874,6414,329,2166,510,3062,507,8631,678,528
Cash payments for principal of loans-7,002,695-3,932,110-5,369,368-4,010,607-2,125,351-1,674,777
Cash payments for interest on loans-695,096-735,066-810,854-438,948-252,837-132,952
Net cash inflow (outflow) from financing activities-528,947-792,535-1,851,0062,044,030129,400-129,201
Net increase (decrease) in cash224,539-203,443-36,793482,825140,94636,912
Cash balance at beginning of year168,414335,267126,93163,301121,559122,614
Effect of changes in exchange rates15,64911,7254,419594580
Cash balance at end of year408,602143,54994,557546,185262,963159,526

Reporting periods

71 periods are on file for this report, from the period ending 1387/12/30 to the period ending 1405/06/31.